Celldex Therapeutics reported $730K in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
AbbVie USD 15.42B 2.08B Jun/2025
Amgen USD 9.18B 1.03B Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Celldex Therapeutics USD 730K 450K Jun/2025
Glaxosmithkline GBP 7.99B 131M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024